New oral cancer drug enters first human trials
Disease control
Recruiting now
This is the first study in humans to test an oral tablet called BB102 for patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also check for early…
Phase: PHASE1 • Sponsor: Broadenbio Ltd., Co. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC